Premium
Postvaccinal, Corticosteroid‐resistant Bullous Pemphigoid in Infancy: Treatment with Intravenous Immunoglobulin
Author(s) -
Ister Marielle,
Pouessel Guillaume,
Ythier Hubert,
Catteau Benoit,
Carpentier Olivier
Publication year - 2014
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.12360
Subject(s) - medicine , bullous pemphigoid , discontinuation , dermatology , pemphigoid , corticosteroid , antibody , immunoglobulin a , immunoglobulin g , immunology , surgery
Abstract Bullous pemphigoid is an autoimmune subepidermal blistering disorder that typically affects elderly adults but can also occur in childhood. We report on a 3‐month‐old boy who developed bullous pemphigoid 1 week after the second routine administration of a hexavalent vaccine. The disease was resistant to standard therapies (including oral and topical corticosteroids) but was relieved by intravenous immunoglobulin treatment. There was no recurrence of bullous pemphigoid after the next vaccination (3 mos after discontinuation of steroids).